Paul Auwaerter is an Infectious Disease physician affiliated with Johns Hopkins University. OpenAlex indexes 13 publications with 318 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10755 Falls Rd
Lutherville, MD 210934515
Telephone
410-583-2727Registry record last updated 24 Jan 2014.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shionogi IncProgram year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
- Shionogi IncProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
48.3%Statin20.5%Atorvastatin Calcium52%Rosuvastatin Calcium36%Simvastatin13%Part D<11 patientsBeta blocker6.9%Metoprolol Succinate100%Part D<11 patients+ 5 more classes in this area
Nervous system
17.7%SSRI5.3%Fluoxetine Hcl62%Escitalopram Oxalate38%Part D<11 patientsGabapentinoids5.1%Pregabalin57%Gabapentin43%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
12.8%Proton pump inhibitor5.5%Pantoprazole Sodium100%Part D<11 patientsH2 blocker2.9%Famotidine100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Racial Disparities in Hesitancy and Utilization of Monoclonal Antibody Infusion Treatment of COVID-19: Lessons for Future Pandemics
Journal of General Internal Medicine
2025 - Feasibility of and Experience With Free State-Funded Telehealth-Based Patient Self-referral for COVID-19 Monoclonal Antibody Therapy
Disaster Medicine and Public Health Preparedness
2023 - Diagnosing the disorders of giants.
PubMed
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”